Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 477

Second Place, Eyeing First

1,404 words 5 min read 1 view 3mo ago Source ​
Skip to the end of the chapter
Prev
Next

Wei Kang sat in his office, looking at the freshly released financial report.

Last year's financial report was released rather late, and it wasn't delivered to his desk until the end of January.

The performance in the sixth year was quite impressive overall, maintaining rapid growth and with revenue exceeding 70 billion, reaching 78.2 billion US dollars.

Compared to the previous year, the main driver of revenue growth was in the medical device sector, which saw remarkable and outstanding progress.

Portable Color Ultrasound, portable medical kits, and Capsule Gastrointestinal Endoscope are very popular in China and are also highly sought after abroad, contributing significantly to sales.

This doesn't even include Artificial Blood and Nano Pill; once these two are launched, this year's performance will definitely reach a new high.

If Three Purities can also capture the market in the endoscopy field, its medical device business will be firmly established.

Wei Kang looked at the data on the pharmaceutical business and frowned.

As he predicted, the growth in sales of HIV treatment drug has stopped and is expected to gradually decline starting next year or the year after.

After all HIV-infected people in China have been cured, the only place that can still support sales is developed countries overseas.

Once HIV patients in the Eagle Country and Europa are cured, this once-dominant King of Anti-AIDS will inevitably decline.

In another two or three years, it will probably become a niche drug and will no longer be able to bring much revenue to the company.

The only remaining success in the fight against AIDS is the drug Severing Love Spirit), which has become the preferred treatment for AIDS patients in many developing countries due to its significantly reduced price.

Seeing this result, Wei Kang couldn't help but smile bitterly.

Sure enough, developing a drug that can completely cure something with a single injection is just digging their own grave. No wonder major pharmaceutical companies are no longer willing to do such a foolish thing, but instead are developing Antihypertensive Drug and Blood-Sugar-Lowering Drug drugs that need to be taken for a long time.

Drugs that can continuously generate revenue for pharmaceutical companies are the real cash cows and star drugs.

Even if their effects are not so good and they cannot cure patients, but can only control the condition, they can keep patients' wallets open and continue to receive money.

Although they are just trickles, they can still converge into rivers and seas, filling the coffers of pharmaceutical companies.

Instead of the current situation where it erupts for two or three years, then abruptly ends and quickly disappears.

Three Purities is now facing the same predicament as Gilead did back then.

The invented drug was so effective that it wiped out patients so completely that it indirectly killed its own business.

In fact, most pharmaceutical companies with a single product category face this dilemma.

Even pharmaceutical giants like Pfizer, Bayer, and Novartis still face the same challenges.

Unlike Gilead, pharmaceutical giants and small and medium-sized pharmaceutical companies are concerned about the expiration of patents.

No matter how effective or amazing a drug is, it only has a 20-year patent. Once the patent expires, the profits that pharmaceutical companies can extract will decrease.

Without new blockbuster drugs to fill the gap, pharmaceutical companies will lose their previous leading position, and may even lose this market entirely due to the impact of generic drugs.

The difficulty of developing new drugs is so great that it is almost impossible, and many pharmaceutical companies have fallen into decline because of this.

The pharmaceutical giants' solution to this problem is to buy, buy, buy.

Spend hundreds of millions or billions to acquire promising new drug projects, complete clinical trials, and launch them to the market, thereby creating new blockbuster drugs.

Anyway, they have plenty of money and they snatch up the best spots everywhere. As long as they buy more pipelines, they can always occupy a lot of slots.

Fortunately, Three Purities is not Gilead, and it doesn't rely solely on this one flagship drug to survive.

It's not like Pfizer, which relies on its financial power to maintain its glory.

Anti-AIDS drugs are just one of Three Purities's many original research drugs, which is why Wei Kang is confident in launching them to the market.

Even without anti-HIV drugs, Three Purities still has a series of new drugs such as Anti-cancer Drug and anti-AD drug.

As long as new drugs are continuously launched every year, Three Purities can maintain its current momentum and move forward at full speed on track.

Years of investment in research and development are now beginning to bear fruit.

Three Purities now has strong independent research and development capabilities, and can develop several original new drugs every year.

Therefore, Wei Kang was full of confidence, feeling that he would definitely not end up in the same situation as Gilead.

Whenever he thinks of Gilead, he immediately pulls out the latest quarterly financial reports of major pharmaceutical giants.

"Haha, so Gilead's market for anti-HIV drugs is also shrinking, even faster than Three Purities."

Looking at his competitor's quarterly report, Wei Kang couldn't help but laugh out loud.

"It seems that if Gilead cannot turn things around in hepatitis B drug, it will likely fall out of the top 20 and become an unknown company soon."

"Hopefully they can find a new trigger point."

Wei Kang shook his head. This was truly a case of success and failure both stemming from the same source. What good could one or two flagship drugs do, even if they achieved a market share of 60% or 80%?

When patients are cured, that's when pharmaceutical companies disappear.

As a pharmaceutical company, he understands the principle of "if you don't move forward, you fall behind" better than anyone else.

Only by constantly innovating and moving forward can we survive in this brutal market and continuously reap excess profits.

However, this is also related to Gilead's area of expertise.

Antiviral drugs are very different from other drugs because they target viruses, which are microorganisms.

Like antibiotics and the immune system, they are engaged in a life-or-death war with invading adversaries, and a final victory must be determined.

The two are simply incapable of coexisting peacefully and living under the same roof.

Medications for treating Diabetes are a supplement to the body's lack of insulin. Just like eating and drinking, insulin needs to be continuously ingested to maintain the balance of the body's basic functions.

Clearly, pharmaceutical companies see the latter as a sustainable and profitable business.

Wei Kang continued to look through the quarterly reports of Johnson & Johnson & Johnson and Pfizer, and soon a joyful smile appeared on his face.

"Finally, we've surpassed Pfizer!" He clenched his fist and excitedly waved it in the air.

"If there are no unforeseen circumstances, Three Purities's revenue last year should have been the second highest in the pharmaceutical industry, second only to Johnson & Johnson."

"Of course, this includes the revenue from Sanqing Medical Equipment business. If we only compare the revenue from pharmaceuticals, then it is still not as good as Pfizer."

"It's not a big problem. Three Purities is also constantly launching new drugs and will soon completely surpass Pfizer in the pharmaceutical field."

"In the sixth year, Three Purities finally ascended to the second position in the world, and with the prospect of becoming number one, the future is promising."

Thinking of this, Wei Kang couldn't help but burst into laughter.

He casually leaned back against the soft, thick chair back, completely relaxed, and his expression became leisurely and carefree.

"Actually, the champion is nothing special. He is just too big to fall because of his years of accumulation. In recent years, Johnson & Johnson has been complacent and has not made any breakthroughs in the fields of pharmaceuticals and medical devices. Hehe, he is completely vulnerable to Three Purities."

"Next year, Three Purities will establish a firm foothold in the medical device field. With a two-pronged approach, it will definitely be able to defeat Johnson & Johnson and take the top spot."

"At that time, the entire medical field will be dominated by Three Purities."

"Let Three Purities lead the way in advancing human medical technology."

Today is Lunar New Year's Eve. I did housework Chinese New Year's Eve and watched the Spring Festival Gala with my parents in the evening, so I'll only write 2000 words.

Happy New Year to everyone! Wishing you all a prosperous Year of the Rabbit! Happy New Year!

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang
Three Purities
China
Eagle Country

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS